CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Chlamydia antibody titre as screening test for tubal factor infertility – a case-control study

Author: 
Adeniyi A. Adewunmi, Tawaqualit A. Ottun, Yusuf A. Oshodi, Fatimat M. Akinlusi and Tawakalit A. Olawepo
Subject Area: 
Health Sciences
Abstract: 

Background: Infertility is a socially distressing medical condition that remains a public health concern in many developing countries including Nigeria. Tubal disease is the most common cause of female infertility in Africa. Sero-epidermiological studies have indicated that Chlamydial infections account for a large proportion of asymptomatic genital tract infections by demonstrating a strong link between tubal pathology and the presence of chlamydial antibodies. OBJECTIVE: To compare the serum Chlamydia antibodies between infertile women with tubal and non-tubal factor infertility. Methodology: Prospective case control study involving one hundred and forty seven subjects with tubal factor infertility (cases) and similar number of subjects with non-tubal factor infertility (controls) following hysterosalpingography. Exclusion criteria were previous clinical or laboratory evidence of pelvic infection in the previous 6 months, history of endometriosis, tubal surgery and abdominal or pelvic surgeries like ruptured appendix and ruptured ectopic. Structured interviewer-administered questionnaire was applied to obtain information on socio-demographic data and relevant gynaecology history. The weight and height were measured and body mass index calculated. Five milliliters of venous blood samples was collected from each subject to assay antibodies to Chlamydia trachomatis using ELISA Ig G kit. The data obtained was processed and analyzed using the Statistical Package for Social Sciences (SPSS), version 20.0 Chicago Illinois. Result: The prevalence of positive Chlamydia trachomatis antibodies was 48% giving a sensitivity of 70.1% and specificity of 74.1%. The accuracy of Chlamydia antibody test to distinguish subjects with bilateral tubal blockage diagnosed with HSG was 72.1%. One hundred and three cases (70.1%) and 38 (25.9%) controls tested positive to the Chlamydia antibody test (P of <0.001). A higher proportion of subjects with induced abortion (54.7%) compared with 42.8% without induced abortion had positive Chlamydia antibody index (p = 0.043) while 51.2% of subjects with secondary infertility compared with 29.8% subjects with primary infertility had positive Chlamydia index (p = 0.007). The median Chlamydia IgG index of subjects with tubal blockage was significantly higher (1.06 IQR 0.59, 1.65) than those without tubal blockage (0.47 IQR 0.29, 0.82) p <0.001. Median Chlamydia IgG index of subjects with history of induced abortion and secondary infertility was significantly higher than subjects with no history of induced abortion and primary infertility respectively (p <0.05). Conclusion: The predictability of tubal blockage using Chlamydia trachomatis antibody was relatively high with sensitivity and specificity of 70.1% and 74.1% respectively. Subjects with secondary infertility had a two-fold chance of having positive Chlamydia index than primary infertility.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran